HOME >> BIOLOGY >> NEWS
Chemists unlock secret to activating tumor suppressor gene

Researchers have discovered the way to activate a key anti-cancer signal that goes AWOL in several gynecologic and brain cancers.

Since the late 1990s, researchers have known that a gene called PTEN (short for phosphatase and tensin homolog on chromosome 10) encodes a signaling protein that suppresses tumor growth. What wasn't known, however, was what mechanism activated PTEN. The answer was found by a group of researchers led by University of Illinois at Chicago chemistry professor Wonhwa Cho. They report their findings in the June 9 online edition of the Proceedings of the National Academy of Sciences.

"The role of PTEN is to counterbalance the action of an enzyme that induces cell growth," said Cho. "Over-activation of the enzyme can lead to cancer. So if you lose a PTEN gene and its cellular activity, the cell goes out of control. It's like a car with an accelerator but without the brakes."

It was generally thought that PTEN was activated by binding to other proteins, giving it a signal to interact with the cell membrane. But Cho said that's not the case.

Cho's group found that PTEN itself can be activated by phosphorylation, or the chemical addition of a phosphate tag.

"We found that the phosphorylation of certain sites of the PTEN protein worked as a switch to completely change its electrostatic property," said Cho. "It switched from being neutral to positively charged, then recognized the opposite charge on the membrane to bind there." Once the bind took hold, the cancer suppression action went to work.

Cho's laboratory used a biophysical technique called surface plasmon resonance analysis and cellular microscopic analysis of green fluorescence protein-labeled PTEN to unlock the secret of its activation. The UIC chemist believes the mechanism described for PTEN is a relatively common way to regulate membrane binding and activation of many cellular proteins involved in cell signaling and membrane traffickin
'"/>

Contact: Paul Francuch
francuch@uic.edu
312-996-3457
University of Illinois at Chicago
10-Jun-2003


Page: 1 2

Related biology news :

1. Chemists at four pharmaceutical companies named Heroes for treating childhood conditions
2. Chemists create unusual lariat RNA, a key intermediate in biological splicing
3. American Institute of Chemists names Ralph Hirschmann AIC Gold Medalist
4. Chemists explore the shape of the key that signals cell division in cancer cells
5. Nanoencapsulation: Chemists at TSRI discover a new and simple way of controlling reactions
6. Chemists characterize regulators of zinc intake and export in cells
7. Chemists spin materials to improve magnetic resonance data
8. Chemists describe "zipper teeth" of DNA molecules -- publish results in the journal Nature
9. Chemists report new approach to synthetic fragments of medically important Heparin
10. Chemists hold national meeting August 22-26
11. Chemists hold national meeting August 22-26 in New Orleans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2019)... , ... February 27, 2019 , ... Fluxion Biosciences, a ... it has received a National Cancer Institute grant for further development of its ERASE-Seq ... with clinical support from the lab of Dr. Omar Mian at the Cleveland Clinic. ...
(Date:2/22/2019)... ... 20, 2019 , ... As technology continues to drive the ... engineering and medical science grows ever thinner. As medical machines and the computers ... making medical practice easier for doctors, more effective for patients and more cost ...
(Date:2/22/2019)... ... 21, 2019 , ... The Virginia Commonwealth University (VCU) College ... a collaborative program to work toward applications of Fuzionaire Dx’s proprietary radiochemistry platform. ... and will explore Fuzionaire Dx’s platform as a unique tool for drug discovery. ...
Breaking Biology News(10 mins):
(Date:2/27/2019)... ... February 26, 2019 , ... Superior Controls, Inc., ... solutions with 140 employees on both the east and west coasts, today announced ... State of New Hampshire. Sandmaier, a senior project engineer, joins Taggart McCormick, P.E., ...
(Date:2/19/2019)... ... February 19, 2019 , ... VetStem Biopharma has long been a ... October 2018, VetStem authorized the formation of Personalized Stem Cells, Inc (“PSC”), a human ... data, and FDA filings to launch into human stem cell clinical therapy. PSC ...
(Date:2/2/2019)... ... January 31, 2019 , ... The top tech companies advancing artificial ... to showcase their tools to the largest gathering of software engineers, data scientists and ... and Mathworks are partnering with the Open Data Science Conference (ODSC) to ...
(Date:1/30/2019)... ... January 29, 2019 , ... ... and Manufacturing Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites ... $59.1 million backed by multiple global investors lead by China's State Development & ...
Breaking Biology Technology:
Cached News: